Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Musculoskeletal
Clinical Trials: Pain
A listing of clinical trials currently looking for volunteers to enroll in Pain studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Children's Hospital of Alabama
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Birmingham : Children's Hospital of Alabama
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Mobile : University of South Alabama, Children's and Women's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Arizona
Goodyear : Dedicated Clinical Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Phoenix : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Phoenix : Advanced Podiatry
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Phoenix : The Office of Joshua D. Holland, M.D.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Phoenix : Clinical Research Consortium Arizona
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
View More »
Phoenix : Precision Trials
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Phoenix : Phoenix Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Scottsdale :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Tucson : Genova Clinical Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Arkansas
Little Rock : Arkansas Children's Hospital
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
California
San Luis Obispo : Coastal Medical Research Group, Inc.
Do You Suffer From Gout? If you are Male and 50 years of age or older, or Female, 55 years of age or older and postmenopausal for at least 2 years, have a history or presence of Gout, have a history of risk of heart events, have hyperuricemia and more than one attack of Gout, you may qualify!
Walnut Creek : Diablo Clinical Research
Is Diabetes causing you PAIN in both legs or both feet… for at least the past six months?
View More »
Beverly Hills : Osteoporosis Medical Center
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Chula Vista :
A Prospective Clinical Outcomes Registry
Fresno : Neuro-Pain Medical Center
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Fresno : Call for Information (Investigational Site 0017)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Fullerton : Call for Information (Investigational Site 0004)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Gilroy : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
La Jolla : University of California at San Diego Medical Center
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
La Jolla : UC San Diego Regional Center
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Lakewood : Center for United Research, Inc.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Loma Linda : Loma Linda University Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Los Angeles : Site: 116
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Los Angeles : HealthCare Partners Medical Group
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Los Angeles : IDS Pharmacy
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Los Angeles : University of Southern California
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Los Angeles : Axis Clinical Trials
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Los Angeles : Children's Hospital Los Angeles
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Los Angeles : Department of Pediatrics - UCLA David Geffen School of Medicine
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Los Angeles : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Madera : Children's Hospital Central California
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Marina del Rey :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Montebello : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Montebello : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Napa : Neurovations (Queen of the Valley Hospital)
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Orange : Site: 112
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Orange : Children's Hospital of Orange County
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Palo Alto : LS Packard Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Paramount : Bayview Research Group, LLC
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Paramount : Bayview Research Group, LLC
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Redondo Beach : Call for Information (Investigational Site 0024)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Sacramento :
A Prospective Clinical Outcomes Registry
San Diego : UCSD Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Spring Valley : Call for Information (Investigational Site 0013)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Colorado
Aurora : The Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Colorado Springs : Lynn Institute of the Rockies
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Colorado Springs : Lynn Institute of the Rockies
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Connecticut
Waterbury : Chase Medical Research, LLC
A Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open-label Run-in to Assess the Efficacy and Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects with Moderate to Severe Chronic Low Back Pain.
Waterbury : Chase Medical Research, LLC
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Efficacy (Compared to Placebo) and the Management of Opioid-induced Constipation (Compared to Oxycodone Controlled-release Tablets (OXY)) in Opioid-experienced Subjects with Uncontrolled Moderate to Severe Chronic Low Back Pain and a History of Opioid-induced Constipation who Require Around-the-clock Opioid Therapy.
Waterbury : Chase Medical Research, LLC
An Open-label, Multicenter Study to Assess the Long-term Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects with Moderate to Severe Chronic Non-malignant and Non-neuropathic Pain.
View More »
Danbury : Danbury Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Hartford : Connecticut Children's Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Milford : Site: 113
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
New Haven : Yale-New Haven Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
New London : Neurological Group, PC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Waterbury : Chase Medical Research, LLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Delaware
Wilmington : Alfred I. duPont Hospital for Children
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Florida
Fort Myers : Clinical Physiology Associates
Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain.
View More »
Clearwater : Site: 107
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Coral Gables : Sanitas Research
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Daytona Beach : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Hallandale Beach : MD Clinical
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Hollywood : Memorial Regional Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Jacksonville : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Miami : Jackson Memorial Hospital/University of Miami
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Miami : Pfizer Investigational Site Updated
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
Miami : Call for Information (Investigational Site 0035)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
New Port Richey : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Orlando : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Orlando : Site: 108
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Palm Beach Gardens : Palm Beach Neurological Center,
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Tampa : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Tampa : Meridien Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Tampa : Tampa General Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Winter Haven : Clinical Research of Central Florida
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Winter Park : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Georgia
Columbus : Southeast Regional Research Group - Columbus
chronic nonmalignant and nonneuropathic pain
Stockbridge : Atlanta Knee and Shoulder Clinic, PC
KNEE PAIN?
View More »
Atlanta : Call for Information (Investigational Site 0026)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Atlanta : Grady Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Columbus : Columbus Research Foundation
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Hiram : WeCareMD, P.C.
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Macon : The Children's Hospital at the Medical Center of Central Georgia
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Stockbridge : Pain Care LLC
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Stockbridge : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Illinois
Bloomington : Millennium Pain Center
A Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study to Evaluate the Safety and Efficacy of CEP-37247 Administered at Single Doses of 0.5, 1, 3, 6, or 12mg by the Transforaminal Epidural Route for the Treatment of Patients with Lumbosacral Radicular Pain Associated with Disk Herniation.
View More »
Chicago : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Chicago : Suburban Clinical Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Chicago : Children's Memorial Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Chicago : Rush University Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Chicago : University of Chicago
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Naperville : Suburban Clinical Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Park Ridge : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Springfield : Southern Illinois University School of Medicine
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Springfield : Call for Information (Investigational Site 0029)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Indiana
Brownsburg : Hendricks Family Medicine
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Chesterton : Duneland Health and Wellness Institute
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Danville : Hendricks Adult Medicine
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Indianapolis : Riley Hosptial for Children at Indiana University
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Muncie :
A Prospective Clinical Outcomes Registry
Iowa
West Des Moines : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Kansas
Kansas City : Univ. of Kansas Medical Center
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Wichita : Wesely Medical Center
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Kentucky
Lexington : University of Kentucky Chandler Medical Center Updated New
Knee Cap Instability and Pain Study
Lexington : University of Kentucky Chandler Medical Center
Non-Invasive Brain Stimulation for Complex Regional Pain Syndrome (CRPS)
View More »
Bardstown : Kentucky Pediatric/Adult Research Updated
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Lexington : Central Kentucky Research Associates, Inc.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Lexington : University of Kentucky
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Lexington : University of Kentucky
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Louisville : Kosair Children's Hospital
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Louisiana
Baton Rouge :
A Prospective Clinical Outcomes Registry
New Orleans : Ochsner Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
New Orleans :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
New Orleans : Ochsner Medical Center
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Maryland
Baltimore : Sinai Hospital of Baltimore
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Baltimore :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Massachusetts
Brockton : Beacon Clinical Research
Low Back Pain
Brockton : Beacon Clinical Research
Pain with every step you take?
Haverhill : ActivMed Practices & Research, Inc.
Do you suffer from Chronic Low Back Pain?
View More »
Boston : Floating Hospital for Children at Tufts Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Boston : Dana Farber Cancer Institute (DFCI)
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Boston : Beth Israel Deaconnes MC Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Brighton : Steward St. Elizabeth's
TAP-patients With Robotic Assisted Lap Prostatectomy
Brockton : Miray Medical Center
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Brockton : Beacon Clinical Research, LLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Fall River : Genesis Clinical Research, LLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Michigan
Ann Arbor : Site: 115
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Bloomfield Hills :
A Prospective Clinical Outcomes Registry
Detroit : Karmanos Cancer Institute
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Detroit : St. John Hospital & Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Farmington Hills : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
View More »
Grand Rapids : Helen DeVos Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Kalamazoo : Western Michigan University
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
Minnesota
Minneapolis : Minneapolis VAMC
Intra-articularInjection of Botulinum Toxin Type
Mississippi
Tupelo : North Mississippi Sports Medicine & Orthopaedic Clinic
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Missouri
St Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have low back pain?
View More »
Columbia : Children's Blood Disorders & Cancer Unit
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Kansas City : Children's Mercy Hospitals and Clinics
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Springfield : Call for Information (Investigational Site 0033)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
St. Louis : Mercy Clinic Children's Cancer and Hematology Center
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
St. Louis : St. John's Mercy Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
St. Louis :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
St. Louis : Call for Information (Investigational Site 0001)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Montana
Great Falls : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Kalispell :
A Prospective Clinical Outcomes Registry
Nebraska
Omaha : Quality Clinical Research, Inc.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Nevada
Las Vegas : Clinical Research Consortium
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Las Vegas : Children's Specialty Center of Nevada
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Las Vegas :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Las Vegas : Clinical Research Center Updated
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
New Hampshire
No Conway : Alan S. Goldenhar, DPM
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
New Jersey
Mount Laurel : CRI WW
Do you or a loved one suffer from Pain due to
View More »
Berlin : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Morristown : Morristown Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
New York
Williamsville : Upstate Clinical Research Associates Updated New
Chronic Pain Study
View More »
Albany : Albany Medical Center
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Bronx : James J. Peters VAMC
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Manhasset : North Shore - Long Island Jewish Health System
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
New York : The Medical Research Network, LLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
New York : Taylor MicroTechnology, Inc.
Evaluation of Pain Location, Pain Quality and Pain Patterns in Subjects With Chronic Pain
New York : NYU Langone Medical Center
Preventing Propofol Injection Pain: Prospective Randomized Trial Comparing Propofol Versus Fospropofol
New York : New York University Langone Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
New York : St Luke's-Roosevelt Hospital Center
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
New York :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
New York : Columbia Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
New York City :
A Prospective Clinical Outcomes Registry
Stony Brook : Stony Brook University Hospital
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Stony Brook : Stony Brook University Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Syracuse :
A Prospective Clinical Outcomes Registry
Syracuse : SUNY Upstate Medical University
Cyclobenzaprine Extended Release (ER) for Fibromyalgia
Utica :
A Prospective Clinical Outcomes Registry
Williamsville :
A Prospective Clinical Outcomes Registry
North Carolina
Raleigh : Wake Research Associates
Adolescent Fibromyalgia Trial
Raleigh : Wake Research Associates
Do you have knee pain?
Raleigh : Wake Research Associates
Pain after shingles?
View More »
Chapel Hill : UNC Hospital Neonatal-Perinatal Medicine
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Charlotte : Presbyterian Blume Pediatric Hematology and Oncology Clinic
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Charlotte : Call for Information (Investigational Site 0023)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Charlotte : Call for Information (Investigational Site 0005)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Durham :
A Prospective Clinical Outcomes Registry
Durham : Duke University Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Durham : Duke University Medical Center Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Flat Rock : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Flat Rock : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Greensboro : Call for Information (Investigational Site 0020)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Raleigh :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Winston Salem : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Winston-Salem : Site: 110
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Winston-Salem : The Center for Clinical Research - Carolina Pain Institute
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Winston-Salem : Wake Forest University Baptist Medical Center Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Ohio
Cincinnati : Radiant Corporate Headquarters
Back Pain Research Study
View More »
Cincinnati : Call for Information (Investigational Site 0021)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Cleveland : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Cleveland : Akron Children's Hospital
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Cleveland : University Hospitals
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Cleveland : University Hospital - Case Medical Center Rainbow Babies & Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Cleveland : Cleveland Clinic Children's Hospital for Rehabilitation
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Cleveland :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Cleveland : Cleveland Clinic
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Cleveland : Fairview Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Columbus : Radiant Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Columbus : The Ohio State University Medical Center Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Kettering : Call for Information (Investigational Site 0022)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Mansfield :
A Prospective Clinical Outcomes Registry
Middletown : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Oklahoma
Oklahoma City :
A Prospective Clinical Outcomes Registry
Oklahoma City : Sooner Clinical Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Oklahoma City : The Office of Veronique Sebastian, MD
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Oklahoma City : The Children's Hospital at Oklahoma University Medical Center
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Oklahoma City : Lynn Health Sciences Institute
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
View More »
Oklahoma City : Department of Pediatrics, University of Oklahoma Health Sciences Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Oklahoma City : The Children's Hospital at OUMC
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Oregon
Bend : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Medford : Sunstone Medical Research, LLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Portland : Legacy Emanuel Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Portland : Oregon Health & Science University
The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women
Pennsylvania
Altoona : Allegheny Pain Management
A Multicenter, Randomized, Saline-Controlled Trial of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) with the Biostat System
View More »
Altoona : Blair Orthopedic Associates, Inc.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Altoona : Call for Information (Investigational Site 0003)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Duncansville : Altoona Center for Clinical Research
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Hershey : Penn State Hershey Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Hershey : Penn State College of Medicine
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Philadelphia : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Pittsburgh : Children's Hospital of Pittsburgh of UPMC
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Wynnewood : Lankenau Updated
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Rhode Island
Cumberland : Call for Information (Investigational Site 0032)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Warwick : Call for Information (Investigational Site 0006)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
South Carolina
Greer : Radiant Research - Greer
Chronic Pain Research Study
View More »
Orangeburg : Neurology and Pain Clinic, LLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Tennessee
Kingsport : Call for Information (Investigational Site 0019)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Knoxville : Complete Family Care of Knoxville, PLLC
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Nashville : Monroe Carell Jr. Children's Hospital at Vanderbilt
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Tullahoma : Call for Information (Investigational Site 0012)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Texas
San Antonio : Radiant Research - San Antonio
Back Pain Research Study
San Antonio : Lung Diagnostics
Now Enrolling – Abdominal Pain Research Study
View More »
Arlington :
A Prospective Clinical Outcomes Registry
Dallas : Site:106
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Dallas : University of Texas Southwestern Medical Center at Dallas
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Dallas : Children's Medical Center of Dallas
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Dallas : Children's Medical Ctr of Dallas
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Dallas : Pfizer Investigational Site Updated
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
Dallas : Parkland Memorial
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Houston : Site: 114
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Houston : Centex Research, Inc.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Houston : Houston Neurocare
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Houston : Thomas Street Health Center-HCHD
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Houston : University of Texas M.D. Anderson Cancer Center
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Houston : Call for Information (Investigational Site 0009)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Irving : Call for Information (Investigational Site 0034)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Laredo : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Plano : Call for Information (Investigational Site 0018)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
San Antonio : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
San Antonio : Site: 105
A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
San Antonio : CHRISTUS Santa Rosa Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
The Woodlands : Research Facility
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Utah
Salt Lake City : Lifetree Clinical Research
Chronic Pain
Salt Lake City : J. Lewis Research, Inc.
Knee pain due to osteoarthritis
View More »
Salt Lake City : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Salt Lake City : Primary Children's Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Salt Lake City : FIRSTMED Updated
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Salt Lake City : Foothill Family Clinic Updated
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
South Jordan : Jordon River Family Medicine Updated
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Virginia
Arlington :
A Prospective Clinical Outcomes Registry
Ettrick : Ettrick Health Center
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Falls Church : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Norfolk :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Norfolk : Call for Information (Investigational Site 0015)
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
View More »
Richmond : Pediatric Hematology and Oncology, Virginia Commonwealth University Health System
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Washington
Edmonds :
A Prospective Clinical Outcomes Registry
West Virginia
Morgantown :
A Prospective Clinical Outcomes Registry
Wisconsin
Milwaukee : Children's Hospital of Wisconsin
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Australia
Adelaide : Southern Adelaide Palliative Services
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Adelaide : Southern Adelaide Palliative Services
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Bentleigh East : Monash Medical Centre, Moorabin Campus
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Bentleigh East : Monash Medical Centre, Moorabin Campus
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Brisbane : Mater Hospitals
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
View More »
Brisbane : Mater Hospitals
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Melbourne : Royal Melbourne Hospital
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Melbourne : Royal Melbourne Hospital
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Prahran : The Alfred Hospital
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Prahran : The Alfred Hospital
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Sydney : Sacred Heart Hospice, St. Vincent's Hospital
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Sydney : Sacred Heart Hospice, St. Vincent's Hospital
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Austria
Klagenfurt : Investigator 4
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Vienna : Investigator 1
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Belgium
Bonheiden : Site: 601
A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients
Brussels : Pfizer Investigational Site Updated
A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Osteoarthritis Of The Knee
Bruxelles : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bruxelles :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Gent : Universitair Ziekenhuis Gent
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
View More »
Leuven : U.Z Leuven - Department of Pediatric Hematology-Oncology
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Brazil
São Paulo : Instituto do Câncer do Estado de São Paulo ICESP
Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy
Bulgaria
Pleven : Investigator 11
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Shoumen : Investigator 4
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Shoumen : Site 1
Tapentadol in Chronic Malignant Tumour Related
Canada
Montreal : CHU Ste-Justine
Effect on Pain of Oral Sucrose Versus Placebo in Children 1 to 3 Months Old Needing Venipuncture
Ottawa : The Ottawa Hospital
A Trial Assessing the Outcome of Celecoxib Administration Versus Placebo Following Anterior Cruciate Ligament (ACL) Reconstruction
Toronto : University Health Network
Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients
Vancouver : WEX Pharmaceuticals Inc.
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Vancouver : University of British Columbia
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
View More »
Vancouver : WEX Pharmaceuticals Inc.
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
China
Beijing : Beijing Hospital of the Ministry of Health
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Beijing : Beijing Tiantan Hospital affiliated to Capital Medical University, Neurology Department
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Beijing : Chinese PLA General Hospital
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Beijing : Endocrinology Department
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Beijing : Peking University Third Hospital
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
View More »
Beijing : Tongren Hospital Affiliated to Capital Medical University
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Changchun : Dept. of Endocrinology, The second hospital of Jilin University
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Guangzhou : GuangZhou First Municipal People's Hospital
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Hangzhou : The Second Affiliated Hospital Zhejiang University College of Medicine
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Harbin : Dept. of Endocrinology, The first Affiliated Hospital of Harbin Medical University
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Harbin : Dept. of Endocrinology, The second Affiliated Hospital of Harbin Medical University
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Jinan : Qilu Hospital of Shandong University
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Jinan : Qilu Hospital of Shandong University/department of internal neurology
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Nanchang : The First Affiliated Hospital of Nanchang University
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Nanjing : Jiangsu Province Hospital
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Shang Hai : Huashan Hospital Affiliated Fudan University, Neurology Department
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Shanghai : Shanghai First People's Hospital
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Shanghai : Renji Hospital Shanghai Jiao Tong University School of Medicine/Neurology Department
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Shanghai : Shanghai Changzheng Hospital
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Wuhan : Tongji Hospital,Tongji Medical College Huazhong University of Science & Technology
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Croatia
Osijek : Investigator 7
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Zabok : Investigator 6
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Zagreb : Investigator 3
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Zagreb : Investigator 2
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Czech Republic
Benesov :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Benešov : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Brno : Investigator 5
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Ceske Budejovice : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Ceske Budejovice :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
View More »
České Budějovice : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Chocen : Site: 908
A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients
Hradec Kralove : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Hradec Kralove : Investigator 6
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Hradec Kralove :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Liberec : Investigator 7
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Most : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Most :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nemocnicni :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nemocnicni : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Nova Ves pod Plesi 110 : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Olomouc : Investigator 8
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Ostrava-Poruba : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Ostrava-Poruba :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Pilsen : Investigator 1
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Plesi :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Plzen : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Plzen :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Policka : Site: 904
A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients
Prague :
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
Praha 10 : Clintrial, s.r.o.
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Sokolov : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Teplice :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Teplice : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Finland
Lahti : Terveystalo Lahti
Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries
Lahti : Terveystalo Lahti
Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries
France
Bayonne : Site 26
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Boulogne-Billancourt : Site 12
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Brest : Site 24
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Corbeil Essonnes : Site 30
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Lille cedex : Site 23
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
View More »
Limoges : Site 17
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
LYON Cedex 08 : Centre Léon Bérard
Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Infiltrations
Nice Cedex 1 : Site 14
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Saint-Etienne cedex 2 : Site 20
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Strasbourg : University Hospital of Strasbourg
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Tarbes : Site 101
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Voiron : Site 28
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
Germany
Bad Klosterlausnitz : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bad Klosterlausnitz :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Berlin : Investigator 23
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Berlin : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bonn : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
View More »
Brasov : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Foscani : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Frankfurt : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Fulda : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Hamburg : Site 24
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Hannover : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Iasi : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Jena :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Jena : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Ludwigsburg : Investigator 7
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Lunen : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Lunen :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Wetlzlar : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Wiesbaden : Investigator 21
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Wiesbaden : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Greece
Athens : Agia Sophia Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Athens : Aglaia Kyriakou - Elpida Children's Oncology Unit
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Athens : Aglaia Kyriakou Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Thessaloniki : AHEPA University General Hospital of Thessaloniki - 2nd University Pediatric Clinic
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Guatemala
Guatemala : Clinica Medica Especializada en Pediatria
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Guatemala : Clinica Privada
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Guatemala : Clinicas Punto Medico
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Guatemala : Clinica Especializada en Ortopedia y Traumatologia
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Quetzaltenango : Unidad de Terapia Intensiva
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
View More »
Quetzaltenango : Clinica Medica Especializada en Pediatria Centro Galo
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Hungary
Budapest : Semmelweis Egyetem, II. sz. Gyermekgyogyaszati Klinika
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Deszk : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Deszk :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Kecskemét : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Komarom : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
View More »
Komarom :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Komárom : Investigator 5
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Miskolc : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Miskolc :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nyiregyhaza : Investigator 2
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Nyiregyhaza : Investigator 1
Tapentadol in Chronic Malignant Tumour Related
Nyíregyháza : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Nyíregyháza :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Szekszard : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Szekszard : Investigator 10
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Szekszard :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Israel
Beer Sheva : Soroka University Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Haifa : Mayer Children Hospital, Rambam Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Jerusalem : Hadassah Medical Organization, Ein Kerem
Phase I Study Evaluating The Safety And Efficacy of a Device for Collection of Electrical Bioimpedance Data
Jerusalem : Hadassah Medical Organization, Ein Kerem
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Petach Tikva : Schneider Children Medical Center of Israel
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
View More »
Ramat Gan : Sheba MC
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
Ramat Gan : Sheba MC
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
Tel HaShomer : Sheba Medical Center
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Japan
Bunkyo : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Chiba : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukui : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukui-Shi : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukushima : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
View More »
Fukushima N/A : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukuyama : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fushimi : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hamamatsu : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hirosaki : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hitachi : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Itami : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Iwakuni : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Izumo N/A : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kamogawa : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kanuma : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kobe : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Koto-Ku : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kumagaya : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kumamoto : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kure : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kyoto : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Matsumoto-City : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Matsusaka : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Meguro : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Minato : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Miyazaki : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Nagoya : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Natori : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Niigata N/A : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Ogori : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Ohta : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Okayama : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Osaka : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Saga : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Saku : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Sapporo : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Sendai : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Sunto : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Takarazuka : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Takasaki : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Tokyo : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Tokyo :
Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuorpathy
Tomakomai : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Toyama : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Toyonaka : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Ube : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yamagata : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yamanashi : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yokohama : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Korea, Republic of
Ansan : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Busan : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Busan : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Cheongju : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Chungcheongbuk-Do : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
View More »
Daegu : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Daegu : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Dae-Gu : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Deajun : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Goyang-Si : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Gyeonggi-Do : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hwasun Gun : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Incheon : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Incheon : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Jinju-Si : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Pusan : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Seognam-Si, Kyungki-Do : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Seoul : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Seoul : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Suwon : Updated
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Suwon : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Wonju-Shi : Updated
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Latvia
Jelgava : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Rezekne : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Rezekne :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Riga : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Riga :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
View More »
Ventspils : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Lithuania
Kaunas : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Klaipeda : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Klaipeda :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Siauliai : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Siauliai :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
View More »
Vilnius : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Vilnius :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Mexico
Chihuahua :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Chihuahua : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Durango : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Mexico : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Netherlands
The Hague : Medical Center Haaglanden
Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome
New Zealand
Christchurch : Christchurch Hospital
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Christchurch : Christchurch Hospital
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Grafton : Starship Children's Health
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Hamilton : Waikato Hospital
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Hamilton : Waikato Hospital
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Poland
Bialystok : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bielsko-Biala :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bielsko-Biala, Slaskie : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bydgoszcz : Investigator 4
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Bygdoszcz : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
View More »
Gliwice : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Gliwice :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Krakow :
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
Lodz : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Lublin : Dzieciecy Szpital Kliniczny im. Prof. Antoniego Gebali
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Poznan : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Poznan :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Warsaw :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Warszawa : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Warszawa : Investigator 1
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Warszawa : Instytut "Pomnik - Centrum Zdrowia Dziecka", Klinika Onkologii
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Warszawa : Instytut Matki i Dziecka
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Wroclaw : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Wroclaw : Samodzielny Publiczny Szpital Kliniczny nr 1 we Wroclawiu
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Portugal
Almada N/A : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Faro : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Setubal : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Puerto Rico
San Juan :
A Prospective Clinical Outcomes Registry
Romania
Baia Mare : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Braila : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Braila :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Brasov : Site 6
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Bucharest : Investigator 2
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
View More »
Bucharest : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bucharest : Investigator 2
Tapentadol in Chronic Malignant Tumour Related
Bucuresti : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bucuresti :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bucuresti : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Cluj : Institutul Oncologic "Prof. Dr. I. Chiricuta", Sectia de Oncopediatrie
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Cluj-Napoca : Investigator 5
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Cluj-Napoca : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Craiova : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Craiova :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Dambovita : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Iasi : Investigator 1
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Iasi : Spitalul Clinic de Urgenta pentru Copii "Sfanta Maria" Iasi, Sectia de Hematologie si Oncologie pediatrica
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Oradea : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Satu Mare : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Sibiu : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Suceava : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Suceava :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Targu Mures : Spitalul Clinic Judetean de Urgenta Targu Mures, Clinica pediatrie I
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Timisoara : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Timisoara : Investigator 7
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Russian Federation
Arkhangels : Site 10
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Nizhniy Novgorod : Investigator 7
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
St-Petersburg : Site in St-Petersburg
A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee
Yaroslavl : Investigator 5
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Serbia
Belgrade : Investigator 5
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Nis : Investigator 2
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Sremska Kamenica : Investigator 1
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Spain
Barcelona : Hospital de la Santa Creu i Sant Pau
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Barcelona : Hospital Sant Joan de Deu
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Barcelona : Hospital Universitario Vall d'Hebron
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Barcelona N/A : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Granada : Site 11
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
View More »
Madrid : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Palma De Mallorca : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Pamplona : Site 12
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Sanchinarro : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Sevilla : Investigator 4
A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Terrasa Barcelona N/A : Updated
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Sweden
Gothenburg : Department of Gastroenterology
Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid
Stockholm : Smärtavdelning B42, Anestesikliniken Karolinska University Hospital, Huddinge
Conversion From Fast Acting Oral Opioids to Abstral®
Stockholm : MR Centre, Dep of Clinical Neuroscience
Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab
Stockholm : Dep of Rheumatology
Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab
United Kingdom
Belfast : Ballygomartin Group Practice Updated
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
Bury : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bury :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bury St. Edmunds : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bury St. Edmunds :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
View More »
Coventry : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Crumpsall :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Crumpsall : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Edinburgh : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Edinburgh :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Glasgow : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Glasgow :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Gorleston on Sea :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Inverness : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
London : Hammersmith Hospital, Imperial College NHS Trust
Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
London : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Manchester : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Manchester : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Norfolk : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Norwich : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Norwich :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nottingham : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Plymouth :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Plymouth : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Sheffield : Royal Hallamshire Hospital
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
Sheffield : Sheffield Children's Hospital
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Surrey : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Weston Super Mare : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Weston Super Mare :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Withington, Manchester :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Wolverhampton : Updated
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Wolverhampton :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
United States
Washington : Children's National Medical Center
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
